"The fact that the jury awarded only a small fraction of Ravgen’s damages claim—less than 15%—and rejected their willfulness claim is an indication that the jury correctly viewed Ravgen’s case as a huge overreach," lead defense attorney Michael Summersgill said.
January 17, 2024 at 02:25 PM
3 minute read
The original version of this story was published on Texas Lawyer
A Maryland biotech company was awarded $57 million in a patent infringement trial, but counsel for the Austin-based defendant considers their loss a win considering what the plaintiff requested.
Ravgen Inc. sued Natera Inc. in 2020 for allegedly infringing on one of its patents.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
